Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedA new site revision tag 'Revision: v3.6.6' has been added. The previous revision tag 'Revision: v3.6.5' has been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.6.5 is now shown, replacing the previous v3.6.4. This change represents a new build/version of the page rather than a modification to study information.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's revision label has been updated from v3.6.3 to v3.6.4, indicating a metadata revision of the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision label has been updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor maintenance update without changes to the study details, eligibility criteria, or locations.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates an update to the page's underlying revision or content, reflecting a maintenance or patch in the site's presentation rather than the clinical study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page adds user guidance sections and updates the Intervention/Treatment labeling, and it now explicitly states that no participants are being recruited.SummaryDifference0.5%

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.